Can I ask how he got the medication and if he had any trouble bringing it into the US? I am trying to arrange to take my father to Cuba to get it and want to avoid any issues. I would love to chat if you are able.
Hi Greg, my mom has Alzheimers and would be a good candidate for the trial in Saskatchewan as she lives in Toronto. I am going to email you. Thank you, Tiff
My husband has been on NeuroEPO for 6 months. He is doing much better. He's happier, engaged with a variety of activities (before, mostly just sat on the sofa), is able to use his mind to process daily life, and much more. He's also a statistician and says the Athenea study on NeuroEPO is "rock solid". There are ways for people in the U.S. to obtain the med from Cuba. It's expensive but less than the cost of two months in memory care.
If the upcoming clinical trial is successful, I feel confident the FDA would grant approval.
I am impressed with everything I have read about the Cuban healthcare and medical research system. I just hope Trump doesn’t try to take over the country.
Yes, that makes sense: that if the Canadian trial is successful then NeuroEPO would get approved in the U.S. I've heard, though, that the Canadian trial could take awhile to complete (maybe 4+ years). That will be a big help for people who are starting down the cognitive impairment path then, but not for people who are struggling with it now.
Can I ask how he got the medication and if he had any trouble bringing it into the US? I am trying to arrange to take my father to Cuba to get it and want to avoid any issues. I would love to chat if you are able.
Do you have any information on enrollment for the trial in Canada? My brother has EOAD but he lives in the US. Not sure if he would be eligible.
I do. Contact me at greg@rowjeraholdings.com
Hi Greg, my mom has Alzheimers and would be a good candidate for the trial in Saskatchewan as she lives in Toronto. I am going to email you. Thank you, Tiff
My husband has been on NeuroEPO for 6 months. He is doing much better. He's happier, engaged with a variety of activities (before, mostly just sat on the sofa), is able to use his mind to process daily life, and much more. He's also a statistician and says the Athenea study on NeuroEPO is "rock solid". There are ways for people in the U.S. to obtain the med from Cuba. It's expensive but less than the cost of two months in memory care.
Thank you for sharing this encouraging news.
If the upcoming clinical trial is successful, I feel confident the FDA would grant approval.
I am impressed with everything I have read about the Cuban healthcare and medical research system. I just hope Trump doesn’t try to take over the country.
Yes, that makes sense: that if the Canadian trial is successful then NeuroEPO would get approved in the U.S. I've heard, though, that the Canadian trial could take awhile to complete (maybe 4+ years). That will be a big help for people who are starting down the cognitive impairment path then, but not for people who are struggling with it now.